Intellectual Property Magazine
Australia agrees to back Covid-19 vaccine IP waiver
Hannah Gannage-Stewart
Australia has agreed to back aTrade-Related Aspects of Intellectual Property Rights (TRIPS) waiver forCovid-19 vaccines, to
enable the manufacture of generic versions in developingnations.